Cargando…

Late relapsing germ cell tumors with elevated tumor markers

PURPOSE: Late relapsing germ cell tumors (LR-GCT) are considered a rare distinct biologic entity as their clinical presentation and response to treatment is different to early recurrences. While serum tumor markers (AFP and ß-HCG) play an important role at the time of first diagnosis to correctly cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Yue, Lusch, Achim, Winter, Christian, Große Siemer, Robert, Buddensieck, Carolin, Albers, Peter, Hiester, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921136/ https://www.ncbi.nlm.nih.gov/pubmed/34518930 http://dx.doi.org/10.1007/s00345-021-03833-z

Ejemplares similares

Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection
por: Hiester, Andreas, et al.
Publicado: (2019)

Surgical treatment of metastatic germ cell cancer
por: Hiester, Andreas, et al.
Publicado: (2021)

How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence
por: Winter, Christian, et al.
Publicado: (2022)

First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group
por: Pfister, David, et al.
Publicado: (2022)

Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer
por: Brandt, Maximilian Peter, et al.
Publicado: (2021)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Management of Late Relapses in Metastatic Testicular Germ Cell Tumors: Still a Challenge
por: Heidenreich, Axel
Publicado: (2021)

Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review
por: Ruf, Christian G., et al.
Publicado: (2022)

Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
por: Seidel, Christoph, et al.
Publicado: (2022)

Mixed germ cell tumor infiltrating the pineal gland without elevated tumor markers: illustrative case
por: Shiomi, Koji, et al.
Publicado: (2021)

Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature
por: Arafat, Waddah, et al.
Publicado: (2014)

Molecular and epigenetic pathogenesis of germ cell tumors
por: Müller, Melanie R., et al.
Publicado: (2021)

In Search of a Germ Theory Equivalent for Chronic Disease
por: Egger, Garry
Publicado: (2012)

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
por: Jay, Alexander P.M., et al.
Publicado: (2021)

Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
por: Majewski, Matthäus, et al.
Publicado: (2023)

Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report
por: Iida, Keitaro, et al.
Publicado: (2014)

Late and Rapid Relapse in Mediastinum from Testicular Germ Cell Tumor Stage I Over 13 Years after Surgery
por: Fukushima, Toshirou, et al.
Publicado: (2019)

Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report
por: Tobiume, Motoi, et al.
Publicado: (2021)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Patrolling Monocytes Watch Over Relapse
por: Tesio, Melania
Publicado: (2020)

Stemness and Relapse: “Chicken or the Egg” Question
por: Tesio, Melania
Publicado: (2021)

Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST - segment elevation myocardial infarction
por: Gerede, Demet Menekşe, et al.
Publicado: (2015)

Clinical and Radiologic Signs of Relapsed Ovarian Germ Cell Tumor: Tissue Is the Issue
por: Homs, M. Y. V., et al.
Publicado: (2013)

Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors
por: McHugh, Deaglan J., et al.
Publicado: (2018)

Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications
por: Moore, Joseph A., et al.
Publicado: (2022)

Relapse-Fated Subclones: Finding the Needle in the Haystack
por: Tesio, Melania
Publicado: (2020)

Successful Outcome of Autologous Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors
por: Mousavi, Seied Aasadollah, et al.
Publicado: (2018)

GERM-01. RECURRENCE PATTERN AND SURVIVAL FOR RELAPSED INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A SINGLE-INSTITUTION EXPERIENCE
por: Wen, Lei
Publicado: (2021)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review
por: Zengerling, Friedemann, et al.
Publicado: (2022)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
por: Hallam, Simon
Publicado: (2018)

Integrating interventional oncology in the treatment of liver tumors
por: Putzer, D., et al.
Publicado: (2018)

Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment
por: van Kessel, Emma, et al.
Publicado: (2017)

Late surgical treatment of tetralogy of Fallot
por: Tchoumi, JCT, et al.
Publicado: (2011)

The Late Dr. W. M. Ord
Publicado: (1902)

Treatment of clinical stage I non-seminoma
por: Winter, Christian, et al.
Publicado: (2021)

Elevated tumor markers for monitoring tumor response to immunotherapy
por: Yang, Yi, et al.
Publicado: (2022)

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
por: Hartung, Hans-Peter, et al.
Publicado: (2015)

Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review
por: Busch, Jonas, et al.
Publicado: (2022)

Retroperitoneal Leiomyosarcoma Associated with an Elevated β-HCG Serum Level Mimicking Extragonadal Germ Cell Tumor
por: Froehner, Michael, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_0mt59bq0k9rme4abq3lec2lood